1. Aresu L, Benali S, Garbisa S, Gallo E, Castagnaro M. Matrix metalloproteinases and their role in the renal epithelial mesenchymal transition. Histol Histopathol. 2011. 26:307–313.
2. Aresu L, Giantin M, Morello E, Vascellari M, Castagnaro M, Lopparelli R, Zancanella V, Granato A, Garbisa S, Aricò A, Bradaschia A, Mutinelli F, Dacasto M. Matrix metalloproteinases and their inhibitors in canine mammary tumors. BMC Vet Res. 2011. 7:33.
Article
3. Cadario ME, Losinno L, Giguere S, Aguilar J, MacPherson M, Fitzpatrick C, Uhl E. Uterine expression of fibrogenic cytokines in the mare. Theriogenology. 2002. 58:449–452.
Article
4. Clutterbuck AL, Harris P, Allaway D, Mobasheri A. Matrix metalloproteinases in inflammatory pathologies of the horse. Vet J. 2010. 183:27–38.
Article
5. de Laat MA, Kyaw-Tanner MT, Nourian AR, McGowan CM, Sillence MN, Pollitt CC. The developmental and acute phases of insulin-induced laminitis involve minimal metalloproteinase activity. Vet Immunol Immunopathol. 2011. 140:275–281.
Article
6. Doig PA, McKnight JD, Miller RB. The use of endometrial biopsy in the infertile mare. Can Vet J. 1981. 22:72–76.
7. Dybdal NO, Daels PF, Couto MA, Hughes JP, Kennedy PC. Investigation of the reliability of a single endometrial biopsy sample, with a note on the correlation between uterine cysts and biopsy grade. J Reprod Fertil Suppl. 1991. 44:697.
8. Fiala SM, Esmeraldino A, Jobim MIM, Garbade P, Wolf CA, Richter G, Gregory RM, Mattos RC. Endometrial fibrotic changes. Is one biopsy enough to diagnose degenerative changes? Anim Reprod Sci. 2010. 121:Suppl. S89–S90.
9. Flores JM, Rodríguez A, Sánchez J, Gómez-Cuétara C, Ramiro F. Endometrosis in mares: incidence of histopathological alterations. Reprod Domest Anim. 1995. 30:61–65.
Article
10. Giantin M, Aresu L, Benali S, Aricò A, Morello EM, Martano M, Vascellari M, Castagnaro M, Lopparelli RM, Zancanella V, Granato A, Mutinelli F, Dacasto M. Expression of matrix metalloproteinases, tissue inhibitors of metalloproteinases and vascular endothelial growth factor in canine mast cell tumours. J Comp Pathol. 2012. Epub ahead of print. doi:
10.1016/j.jcpa.2012.01.011.
Article
11. Hoffmann C, Ellenberger C, Mattos RC, Aupperle H, Dhein S, Stief B, Schoon HA. The equine endometrosis: new insights into the pathogenesis. Anim Reprod Sci. 2009. 111:261–278.
Article
12. Kenney RM. Cyclic and pathologic changes of the mare endometrium as detected by biopsy, with a note on early embryonic death. J Am Vet Med Assoc. 1978. 172:241–262.
13. Kenney RM, Doig PA. Morrow DA, editor. Equine endometrial biopsy. Current Therapy in Theriogenology. 1986. 2nd ed. Philadelphia: Saunders;723–729.
14. Kenney RM, Ganjam VK. Selected pathological changes of the mare uterus and ovary. J Reprod Fertil Suppl. 1975. 335–339.
15. Loftus JP, Belknap JK, Black SJ. Matrix metalloproteinase-9 in laminae of black walnut extract treated horses correlates with neutrophil abundance. Vet Immunol Immunopathol. 2006. 113:267–276.
Article
16. Loftus JP, Johnson PJ, Belknap JK, Pettigrew A, Black SJ. Leukocyte-derived and endogenous matrix metalloproteinases in the lamellae of horses with naturally acquired and experimentally induced laminitis. Vet Immunol Immunopathol. 2009. 129:221–230.
Article
17. McCawley LJ, Matrisian LM. Matrix metalloproteinases: they're not just for matrix anymore! Curr Opin Cell Biol. 2001. 13:534–540.
Article
18. Mishra B, Kizaki K, Koshi K, Ushizawa K, Takahashi T, Hosoe M, Sato T, Ito A, Hashizume K. Expression of extracellular matrix metalloproteinase inducer (EMMPRIN) and its related extracellular matrix degrading enzymes in the endometrium during estrous cycle and early gestation in cattle. Reprod Biol Endocrinol. 2010. 8:60.
Article
19. Mott JD, Werb Z. Regulation of matrix biology by matrix metalloproteinases. Curr Opin Cell Biol. 2004. 16:558–564.
Article
20. Nagase H, Visse R, Murphy G. Structure and function of matrix metalloproteinases and TIMPs. Cardiovasc Res. 2006. 69:562–573.
Article
21. Osenkowski P, Toth M, Fridman R. Processing, shedding, and endocytosis of membrane type 1-matrix metalloproteinase (MT1-MMP). J Cell Physiol. 2004. 200:2–10.
Article
22. Ricketts SW, Alonso S. The effect of age and parity on the development of equine chronic endometrial disease. Equine Vet J. 1991. 23:189–192.
Article
23. Skinner JL, Riley SC, Gebbie AE, Glasier AF, Critchley HO. Regulation of matrix metalloproteinase-9 in endometrium during the menstrual cycle and following administration of intrauterine levonorgestrel. Hum Reprod. 1999. 14:793–799.
Article
24. Troedsson MHT. Robinson NE, editor. Diseases of the uterus. Current Therapy in Equine Medicine. 1997. 4th ed. Philadelphia: Saunders;517–523.
25. Uekita T, Tanaka SS, Sato H, Seiki M, Tojo H, Tachi C. Expression of membrane-type 1 matrix metalloproteinase (MT1-MMP) mRNA in trophoblast and endometrial epithelial cell populations of the synepitheliochorial placenta of goats (Capra hircus). Arch Histol Cytol. 2001. 64:411–424.
Article
26. Visse R, Nagase H. Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry. Circ Res. 2003. 92:827–839.
27. Walter I, Handler J, Miller I, Aurich C. Matrix metalloproteinase 2 (MMP-2) and tissue transglutaminase (TG 2) are expressed in periglandular fibrosis in horse mares with endometrosis. Histol Histopathol. 2005. 20:1105–1113.
28. Walter I, Handler J, Reifinger M, Aurich C. Association of endometriosis in horses with differentiation of periglandular myofibroblasts and changes of extracellular matrix proteins. Reproduction. 2001. 121:581–586.
Article
29. Zhang J, Salamonsen LA. Tissue inhibitor of metalloproteinases (TIMP)-1, -2 and -3 in human endometrium during the menstrual cycle. Mol Hum Reprod. 1997. 3:735–741.
Article